CausalSentinel

Protein Dossier — WARS (Tryptophan–tRNA ligase, cytoplasmic)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Age at menarche -0.114 0.0267 2.10e-05 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertension -0.064 0.0194 9.79e-04 Wald ratio 1 cis NA
Total cholesterol 0.0788 0.0239 9.84e-04 Wald ratio 1 cis NA
LDL cholesterol 0.0776 0.0247 0.00167 Wald ratio 1 cis NA
Celiac disease 0.276 0.0879 0.00171 Wald ratio 1 cis NA
Diagnoses - main ICD10: G56 Mononeuropathies of upper limb 0.201 0.0668 0.00261 Wald ratio 1 cis NA
Fasting glucose 0.0431 0.0145 0.00295 Wald ratio 1 cis NA
Diagnoses - main ICD10: C61 Malignant neoplasm of prostate 0.287 0.0995 0.00387 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoporosis 0.197 0.0708 0.00544 Wald ratio 1 cis NA
Systolic blood pressure automated reading 0.028 0.0109 0.0105 Wald ratio 1 cis NA
Diagnoses - main ICD10: M16 Coxarthrosis [arthrosis of hip] 0.187 0.0743 0.012 Wald ratio 1 cis NA
Transferrin -0.115 0.0482 0.0176 Wald ratio 1 cis NA
…and 114 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

No GWAS Catalog associations mapped to this gene.

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 608 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 0.693 established (curated) no MR -> candidate analysis
complex neurodevelopmental disorder 0.608 established (curated) no MR -> candidate analysis
autosomal recessive primary microcephaly 0.608 established (curated) no MR -> candidate analysis
neuronopathy, distal hereditary motor, type 9 0.538 established (curated) no MR -> candidate analysis
diabetes mellitus 0.469 common-variant locus no MR -> candidate analysis
adolescent idiopathic scoliosis 0.403 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.337 common-variant locus no MR -> candidate analysis
hereditary disease 0.317 established (curated) no MR -> candidate analysis
vertebral disorder 0.279 common-variant locus no MR -> candidate analysis
schizophrenia 0.182 established (curated) MR: beta=-0.0447, p=0.346 (cis)
asthma 0.152 0.152 exploratory rare-variant signal MR: beta=0.0254, p=0.385 (cis)

Of the 11 rows above, 9 have no MR estimate in this resource. Across all retrieved diseases for this gene: 1 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Tryptophan–tRNA ligase, cytoplasmic)
gnomAD constraint not available
GWAS Catalog no mapped SNPs
ClinVar no records
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance